Wendy Clarke

1.1k total citations
15 papers, 671 citations indexed

About

Wendy Clarke is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Wendy Clarke has authored 15 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Pharmacology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Wendy Clarke's work include Receptor Mechanisms and Signaling (4 papers), Neuropeptides and Animal Physiology (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Wendy Clarke is often cited by papers focused on Receptor Mechanisms and Signaling (4 papers), Neuropeptides and Animal Physiology (4 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Wendy Clarke collaborates with scholars based in United States, India and Germany. Wendy Clarke's co-authors include Patrick Brassil, James R. Burke, Kim W. McIntyre, Yuping Qiu, Mark A. Pattoli, Joann Strnad, John F. MacMaster, Xiaoxia Yang, Kurt R. Gregor and F. Christopher Zusi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Archives of Biochemistry and Biophysics.

In The Last Decade

Wendy Clarke

15 papers receiving 652 citations

Peers

Wendy Clarke

IMMUN

ONCOL

F. Christopher Zusi United States

Letizia Crocetti Italy

Sachiko Sakakibara Japan

Thao Perry United States

Anna Rolando United States

Shanshan Deng United States

Vidula Sukhatme United States

Sumeer Dhar Sweden

Irida Kastrati United States

Jeffrey O. Saunders United States

F. Christopher Zusi United States

Wendy Clarke

561 ×1.7

373 ×1.5

296 ×1.7

IMMUN

135 ×1.0

217 ×1.7

ONCOL

Citations per year, relative to Wendy Clarke Wendy Clarke (= 1×) peers F. Christopher Zusi

Countries citing papers authored by Wendy Clarke

Since Specialization

Citations

This map shows the geographic impact of Wendy Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Clarke more than expected).

Fields of papers citing papers by Wendy Clarke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendy Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Clarke. The network helps show where Wendy Clarke may publish in the future.

Co-authorship network of co-authors of Wendy Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Clarke. A scholar is included among the top collaborators of Wendy Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Clarke. Wendy Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Hartz, Richard A., Vijay T. Ahuja, Prasanna Sivaprakasam, et al.. (2023). Design, Structure–Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-b]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors. Journal of Medicinal Chemistry. 66(6). 4231–4252. 19 indexed citations

Hartz, Richard A., Vijay T. Ahuja, Guanglin Luo, et al.. (2023). Discovery of 2-(Anilino)pyrimidine-4-carboxamides as Highly Potent, Selective, and Orally Active Glycogen Synthase Kinase-3 (GSK-3) Inhibitors. Journal of Medicinal Chemistry. 66(11). 7534–7552. 13 indexed citations

Guarino, Victor R., Richard E. Olson, Ivar M. McDonald, et al.. (2019). An amide-based sulfenamide prodrug of gamma secretase inhibitor BMS–708163 delivers parent drug from an oral conventional solid dosage form in male beagle dog. Bioorganic & Medicinal Chemistry Letters. 30(3). 126856–126856. 8 indexed citations

Luo, Guanglin, Ling Chen, Catherine R. Burton, et al.. (2016). Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors. Journal of Medicinal Chemistry. 59(3). 1041–1051. 56 indexed citations

Luo, Guanglin, Ling Chen, Shuanghua Hu, et al.. (2013). Heterocyclic modification of a novel bicyclo[3.1.0]hexane NPY1 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 23(13). 3814–3817. 2 indexed citations

Hu, Shuanghua, Milind Deshpande, Guanglin Luo, et al.. (2012). Discovery of a Novel Class of Bicyclo[3.1.0]hexanylpiperazines as Noncompetitive Neuropeptide Y Y1 Antagonists. ACS Medicinal Chemistry Letters. 3(3). 222–226. 2 indexed citations

Velaparthi, Upender, Mark G. Saulnier, Mark D. Wittman, et al.. (2010). Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one. Bioorganic & Medicinal Chemistry Letters. 20(10). 3182–3185. 16 indexed citations

Meredith, Jere E., Donna M. Barten, Catherine R. Burton, et al.. (2010). P4‐020: Separation of Aβ Reduction from Notch Toxicity with Gamma Secretase Inhibitors in Rats. Alzheimer s & Dementia. 6(4S_Part_20). 1 indexed citations

Belema, Makonen, Amy Bunker, Van N. Nguyen, et al.. (2007). Synthesis and structure–activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-β inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(15). 4284–4289. 26 indexed citations

10.

Gillman, Kevin W., Graham S. Poindexter, Wendy Clarke, et al.. (2006). Synthesis and evaluation of 5,5-diphenylimidazolones as potent human neuropeptide Y5 receptor antagonists. Bioorganic & Medicinal Chemistry. 14(16). 5517–5526. 17 indexed citations

11.

Taber, Matthew T., Thaddeus F. Molski, Wendy Clarke, et al.. (2005). Neurochemical, pharmacokinetic, and behavioral effects of the novel selective serotonin reuptake inhibitor BMS-505130. Pharmacology Biochemistry and Behavior. 80(3). 521–528. 17 indexed citations

12.

Poindexter, Graham S., Marc A. Bruce, J. Guy Breitenbucher, et al.. (2003). Dihydropyridine neuropeptide Y Y1 receptor antagonists 2. Bioorganic & Medicinal Chemistry. 12(2). 507–521. 48 indexed citations

13.

Burke, James R., Mark A. Pattoli, Kurt R. Gregor, et al.. (2003). BMS-345541 Is a Highly Selective Inhibitor of IκB Kinase That Binds at an Allosteric Site of the Enzyme and Blocks NF-κB-dependent Transcription in Mice. Journal of Biological Chemistry. 278(3). 1450–1456. 439 indexed citations

14.

Yonaha, Masanori, Yoshiko Tampo, Wendy Clarke, Harold W. Davis, & John B. Schenkman. (1992). Cholate solubilization of liver microsomal membrane components which promote NADPH-supported lipid peroxidation. Archives of Biochemistry and Biophysics. 292(1). 62–69. 6 indexed citations

15.

Mahlum, D.D., et al.. (1963). METABOLISM AND TOXICITY OF NP-237 IN THE RAT. HW-76000.. PubMed. 86. 22–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact